 | Study programme 2025-2026 | Français | |
 | Technologie pharmaceutique: galénique & biopharmacie - Partie 2 | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M1-PHARMA-007-M | Compulsory UE | VANDERBIST Francis | M111 - Pharmacie Galénique et Biopharmacie |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 40 | 0 | 0 | 0 | 0 | 5 | 5.00 | 2nd term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-PGAL-089 | Technologie Pharmaceutique: galénique & biopharmacie - Partie 2 | 40 | 0 | 0 | 0 | 0 | Q2 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
PART 2 (Q2)
*Chapter 10: Powders
*Chapter 11 : Hard and soft capsules
*Chapter 12 : Tablets
*Chapter 13 : Coated pharmaceutical formulations
*Chapter 14 : Controlled-release oral formulations
*Chapter 15 : Transdermal formulations (patches)
*Chapter 16 : Pulmonary delivery of drugs
*Chapter 17 : Parenteral delivery of drugs
+ CHAPTER 1: BIOPHARMACY
UE Content: description and pedagogical relevance
PART 2 (Q2)
*Chapter 10: Powders
*Chapter 11 : Hard and soft capsules
*Chapter 12 : Tablets
*Chapter 13 : Coated pharmaceutical formulations
*Chapter 14 : Controlled-release oral formulations
*Chapter 15 : Transdermal formulations (patches)
*Chapter 16 : Pulmonary delivery of drugs
*Chapter 17 : Parenteral delivery of drugs
+ CHAPTER 1 : BIOPHARMACY
Prior Experience
UM-B3-PHARMA-023-M
PHYSICO-CHEMICAL PRINCIPLES APPLIED TO THE PHARMACEUTICAL TECHNOLOGY
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-PGAL-089 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-PGAL-089 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-PGAL-089 | PART 2 (Q2) This temporary program can be modified via the addition or the suppression of some chapters *Chapter 10: Powders *Chapter 11 : Hard and soft capsules *Chapter 12 : Tablets *Chapter 13 : Coated pharmaceutical formulations *Chapter 14 : Controlled-release oral formulations *Chapter 15 : Transdermal formulations (patches) *Chapter 16 : Pulmonary delivery of drugs *Chapter 17 : Parenteral delivery of drugs + CHAPTER 1: BIOPHARMACY |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-PGAL-089 | syllabus of TP (lab work) and main bibliography for theory and labwork |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-PGAL-089 | main bibliography for theory and labwork |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-PGAL-089 | Authorized |
Term 2 Assessment - type
| AA | Type(s) and mode(s) of Q2 assessment |
|---|---|
| M-PGAL-089 |
|
Term 2 Assessment - comments
| AA | Term 2 Assessment - comments |
|---|---|
| M-PGAL-089 | The teacher as ticked, as a type of evaluation, ORAL EXAM: - the AA will be validated If the note of the ORAL exam is superior or equal to 10.0 / 20. |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-PGAL-089 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-PGAL-089 | Idem Q2 |